XML 23 R11.htm IDEA: XBRL DOCUMENT
v3.21.2

Earnings per Share | 9 Months Ended
--- | ---
Sep. 30, 2021
Earnings per Share [Abstract] |
Earnings per Share | Note 3 – Earnings per Share The following table sets forth the computation of earnings per share.
|  | Three months ended |  |  | Nine months ended |
|  | September 30, |  |  | September 30, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Net income applicable to common stock |  | $ | 7,064 |  |  | $ | 8,007 |  |  | $ | 22,174 |  |  | $ | 17,876 |
Basic earnings per share computation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding |  |  | 3,949,508 |  |  |  | 3,956,997 |  |  |  | 3,945,962 |  |  |  | 3,808,264 |
Earnings per share - basic |  | $ | 1.79 |  |  | $ | 2.02 |  |  | $ | 5.62 |  |  | $ | 4.69 |
Diluted earnings per share computation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding for basic earnings per share |  |  | 3,949,508 |  |  |  | 3,956,997 |  |  |  | 3,945,962 |  |  |  | 3,808,264 |
Add: Dilutive effects of restricted stock |  |  | 95 |  |  |  | - |  |  |  | 7 |  |  |  | 2,025 |
Weighted average common shares outstanding for dilutive earnings per share |  |  | 3,949,603 |  |  |  | 3,956,997 |  |  |  | 3,945,969 |  |  |  | 3,810,289 |
Earnings per share - diluted |  | $ | 1.79 |  |  | $ | 2.02 |  |  | $ | 5.62 |  |  | $ | 4.69 |
For the three months ended September 30, 2021 and 2020, there were 4,977 and 9,480 shares, respectively, related to the restricted stock plan that were excluded from the diluted earnings per share calculations since they were anti-dilutive. These anti-dilutive shares had per share prices ranging from $57.39-$63.19 for the three month period ended September 30, 2021 and per share prices ranging from $51.14-$62.93 for the three month period ended September 30, 2020. For the nine months ended September 30, 2021 and 2020, 6,000 and 5,347 shares, respectively, related to the restricted stock plan were excluded from the diluted earnings per share calculations since they were anti-dilutive. These anti-dilutive shares had prices ranging from $51.14-$63.19 for the nine month period ended September 30, 2021 and prices ranging from $58.37-$62.93 for the nine month period ended September 30, 2020.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration